A revolutionary oral monthly pill designed to prevent HIV, alimatravir (also known as MK-8527), produced by Merck Sharp & Dohme (MSD), is currently undergoing highly promising phase three trials. If ...
Not just the news — We bring the meaning behind it. Cutting through the noise with depth, clarity, and perspective that others miss.
About Afrikeye · Editorial Standards · Corrections Policy · Contact · Privacy Policy
